Detalhe da pesquisa
1.
Organoid cultures derived from patients with advanced prostate cancer.
Cell
; 159(1): 176-187, 2014 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25201530
2.
Clinical Impact of a Rapid Genetic Testing Model for Advanced Prostate Cancer Patients.
J Urol
; 209(5): 918-927, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36974724
3.
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial.
Lancet Oncol
; 23(3): 362-373, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35131040
4.
Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.
Prostate
; 82(11): 1107-1116, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35538298
5.
Analysis of AR-FL and AR-V1 in Whole Blood of Patients with Castration Resistant Prostate Cancer as a Tool for Predicting Response to Abiraterone Acetate.
J Urol
; 204(1): 71-78, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32068491
6.
A phase I study of the antibody drug conjugate ASG-5ME, an SLC44A4-targeting antibody carrying auristatin E, in metastatic castration-resistant prostate cancer.
Invest New Drugs
; 37(5): 1052-1060, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30725389
7.
Pharmacokinetics and Biodistribution of a [89Zr]Zr-DFO-MSTP2109A Anti-STEAP1 Antibody in Metastatic Castration-Resistant Prostate Cancer Patients.
Mol Pharm
; 16(7): 3083-3090, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31117485
9.
Antibody-Drug Conjugates in Prostate Cancer.
Clin Adv Hematol Oncol
; 18(8): 447-449, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32903243
10.
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study.
Cancer Discov
; 14(1): 76-89, 2024 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37861461
11.
Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer.
Oncologist
; 18(2): 163-73, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23340005
12.
Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study.
Lancet Oncol
; 13(11): 1114-24, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23059046
13.
Cancer Associated Macrophage-like Cells Are Prognostic for Highly Aggressive Prostate Cancer in Both the Non-Metastatic and Metastatic Settings.
Cancers (Basel)
; 15(14)2023 Jul 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509385
14.
PSMA-positive Circulating Tumor Cell Detection and Outcomes with Abiraterone or Enzalutamide Treatment in Men with Metastatic Castrate-resistant Prostate Cancer.
Clin Cancer Res
; 29(10): 1929-1937, 2023 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36897758
15.
Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer.
J Immunother Precis Oncol
; 6(4): 162-169, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38143953
16.
Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects.
J Manag Care Spec Pharm
; 29(7): 758-768, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37404070
17.
Gene-based Confirmatory Germline Testing Following Tumor-only Sequencing of Prostate Cancer.
Eur Urol
; 83(1): 29-38, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36115772
18.
Automated Bone Scan Index to Optimize Prostate Cancer Working Group Radiographic Progression Criteria for Men With Metastatic Castration-Resistant Prostate Cancer.
Clin Genitourin Cancer
; 20(3): 270-277, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35279418
19.
Differences in Prostate Cancer Genomes by Self-reported Race: Contributions of Genetic Ancestry, Modifiable Cancer Risk Factors, and Clinical Factors.
Clin Cancer Res
; 28(2): 318-326, 2022 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34667026
20.
Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study.
Lancet
; 375(9724): 1437-46, 2010 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-20398925